ASF
ASF, licence 80044303: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Biomed International Products Corp.
- NPN or DIN-HM
- 80044303
- Status
- Active licence
- Licence date
- 22 August 2013
- Revision date
- 19 March 2019
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide d-pantothénique Source : D-Pantothénate de calcium | 160.0 milligramme | Not calculated |
| Glycyrrhiza glabra Source : Racine | 100.0 milligramme | Not calculated |
| Eleutherococcus senticosus Source : Racine Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100.0 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, Dioxyde de silicium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 3.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Siberian ginseng is used in Herbal Medicine as a tonic to help relieve general debility and/or to aid during convalescence and to help improve mental and/or physical performance after periods of mental and/or physical exertion. Vitamin C and Vitamin B5 are factors in the maintenance of good health. Rhodiola is used in Herbal Medicine as an adaptogen to help temporarily relieve symptoms of stress such as mental fatigue and sensation of weakness. Rhodiola is used in Herbal Medicine to help support cognitive function such as mental focus and stamina.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you have high blood pressure.
Source
Official Health Canada record, licence 80044303
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.